Ravindra Uppaluri, MD, PhD, lead investigator of the phase 3 KEYNOTE-689 trial (NCT03765918), highlights the potential of pembrolizumab (Keytruda; Merck) to improve outcomes following head and neck ...

Repair Your Hair Damage Here ⬇️ Get glaze here- <a href=" SHOP my Natural Hair Products here- <a href=" Instagram & Tiktok ...

A SURGEON has warned Katie Price is ‘dicing with death’ as she undergoes ‘riskiest surgery yet’. It comes as media ...